Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies

Patients with inflammatory arthritis (IA) are at increased risk of severe COVID-19 due to medication-induced immunosuppression that impairs host defenses. The aim of this study was to assess antibody and B cell responses to COVID-19 mRNA vaccination in IA patients receiving immunomodulatory therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jenny M., Figueroa, Alexis, Sachithanandham, Jaiprasath, Li, Maggie, Connolly, Caoilfhionn M., Shapiro, Janna R., Chen, Yiqun, Jones, Michelle, Dhara, Venkata Gayatri, Towns, Marilyn, Lee, John S., Peralta, Stephanie R., Milstone, Aaron M., Betenbaugh, Michael, Debes, Amanda K., Blankson, Joel, Sitaras, Ioannis, Yoon, Steve, Thompson, Elizabeth A., Bingham, Clifton O., Klein, Sabra L., Pekosz, Andrew, Bailey, Justin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646683/
https://www.ncbi.nlm.nih.gov/pubmed/38022602
http://dx.doi.org/10.3389/fimmu.2023.1266370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646683/
https://www.ncbi.nlm.nih.gov/pubmed/38022602
http://dx.doi.org/10.3389/fimmu.2023.1266370

Ejemplares similares